6EVQ

solution NMR structure of EB1 C terminus (191-260) with a small molecule bound into the SxIP binding site

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1 mM [U-13C; U-15N] EB1, 5 mM 2-(1-cyclopentyltetrazol-5-yl)sulfanyl-N-(2-furylmethyl)propanamide	90% H2O/10% D2O	50 mM	6.5	1 atm	298	Bruker AvanceIII 800
2	2D 1H-13C HSQC aliphatic	1 mM [U-13C; U-15N] EB1, 5 mM 2-(1-cyclopentyltetrazol-5-yl)sulfanyl-N-(2-furylmethyl)propanamide	90% H2O/10% D2O	50 mM	6.5	1 atm	298	Bruker AvanceIII 800
3	2D 1H-13C HSQC aromatic	1 mM [U-13C; U-15N] EB1, 5 mM 2-(1-cyclopentyltetrazol-5-yl)sulfanyl-N-(2-furylmethyl)propanamide	90% H2O/10% D2O	50 mM	6.5	1 atm	298	Bruker AvanceIII 800
4	3D CBCA(CO)NH	1 mM [U-13C; U-15N] EB1, 5 mM 2-(1-cyclopentyltetrazol-5-yl)sulfanyl-N-(2-furylmethyl)propanamide	90% H2O/10% D2O	50 mM	6.5	1 atm	298	Bruker AvanceIII 800
5	3D HBHA(CO)NH	1 mM [U-13C; U-15N] EB1, 5 mM 2-(1-cyclopentyltetrazol-5-yl)sulfanyl-N-(2-furylmethyl)propanamide	90% H2O/10% D2O	50 mM	6.5	1 atm	298	Bruker AvanceIII 800
10	3D 1H-13C NOESY aliphatic	1 mM [U-13C; U-15N] EB1, 5 mM 2-(1-cyclopentyltetrazol-5-yl)sulfanyl-N-(2-furylmethyl)propanamide	90% H2O/10% D2O	50 mM	6.5	1 atm	298	Bruker AvanceIII 800
9	3D 1H-13C NOESY aromatic	1 mM [U-13C; U-15N] EB1, 5 mM 2-(1-cyclopentyltetrazol-5-yl)sulfanyl-N-(2-furylmethyl)propanamide	90% H2O/10% D2O	50 mM	6.5	1 atm	298	Bruker AvanceIII 800
8	2D 1H-1H NOESY	1 mM [U-13C; U-15N] EB1, 5 mM 2-(1-cyclopentyltetrazol-5-yl)sulfanyl-N-(2-furylmethyl)propanamide	90% H2O/10% D2O	50 mM	6.5	1 atm	298	Bruker AvanceIII 800
7	2D 1H-1H TOCSY	1 mM [U-13C; U-15N] EB1, 5 mM 2-(1-cyclopentyltetrazol-5-yl)sulfanyl-N-(2-furylmethyl)propanamide	90% H2O/10% D2O	50 mM	6.5	1 atm	298	Bruker AvanceIII 800
6	3D HCCH-TOCSY	1 mM [U-13C; U-15N] EB1, 5 mM 2-(1-cyclopentyltetrazol-5-yl)sulfanyl-N-(2-furylmethyl)propanamide	90% H2O/10% D2O	50 mM	6.5	1 atm	298	Bruker AvanceIII 800
11	3D 1H-15N NOESY	1 mM [U-13C; U-15N] EB1, 5 mM 2-(1-cyclopentyltetrazol-5-yl)sulfanyl-N-(2-furylmethyl)propanamide	90% H2O/10% D2O	50 mM	6.5	1 atm	298	Bruker AvanceIII 800

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AvanceIII	600
2	Bruker	AvanceIII	800

NMR Refinement
Method	Details	Software
simulated annealing		CNS

NMR Ensemble Information
Conformer Selection Criteria	all calculated structures submitted
Conformers Calculated Total Number	20
Conformers Submitted Total Number	20
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	CNS		Brunger A. T. et.al.
2	structure calculation	ARIA		Linge, O'Donoghue and Nilges
3	chemical shift assignment	CcpNmr Analysis		CCPN
4	peak picking	CcpNmr Analysis		CCPN

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.